GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetics Generation Advancement Corp (ROCO:4160) » Definitions » PS Ratio

Genetics Generation Advancement (ROCO:4160) PS Ratio : 2.25 (As of Apr. 16, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Genetics Generation Advancement PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Genetics Generation Advancement's share price is NT$55.60. Genetics Generation Advancement's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was NT$24.68. Hence, Genetics Generation Advancement's PS Ratio for today is 2.25.

The historical rank and industry rank for Genetics Generation Advancement's PS Ratio or its related term are showing as below:

ROCO:4160' s PS Ratio Range Over the Past 10 Years
Min: 1.02   Med: 1.8   Max: 5.21
Current: 2.26

During the past 13 years, Genetics Generation Advancement's highest PS Ratio was 5.21. The lowest was 1.02. And the median was 1.80.

ROCO:4160's PS Ratio is ranked better than
51.89% of 212 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.62 vs ROCO:4160: 2.26

Genetics Generation Advancement's Revenue per Sharefor the three months ended in Dec. 2024 was NT$5.77. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was NT$24.68.

During the past 12 months, the average Revenue per Share Growth Rate of Genetics Generation Advancement was 11.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 8.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 9.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 10.20% per year.

During the past 13 years, Genetics Generation Advancement's highest 3-Year average Revenue per Share Growth Rate was 17.70% per year. The lowest was -25.00% per year. And the median was 8.30% per year.

Back to Basics: PS Ratio


Genetics Generation Advancement PS Ratio Historical Data

The historical data trend for Genetics Generation Advancement's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetics Generation Advancement PS Ratio Chart

Genetics Generation Advancement Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.35 1.16 1.22 1.68 2.78

Genetics Generation Advancement Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.68 1.71 4.74 3.71 2.78

Competitive Comparison of Genetics Generation Advancement's PS Ratio

For the Diagnostics & Research subindustry, Genetics Generation Advancement's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genetics Generation Advancement's PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetics Generation Advancement's PS Ratio distribution charts can be found below:

* The bar in red indicates where Genetics Generation Advancement's PS Ratio falls into.


;
;

Genetics Generation Advancement PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Genetics Generation Advancement's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=55.60/24.675
=2.25

Genetics Generation Advancement's Share Price of today is NT$55.60.
Genetics Generation Advancement's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$24.68.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Genetics Generation Advancement  (ROCO:4160) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Genetics Generation Advancement PS Ratio Related Terms

Thank you for viewing the detailed overview of Genetics Generation Advancement's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetics Generation Advancement Business Description

Traded in Other Exchanges
N/A
Address
No. 28, Lane 36, Xinhu 1st Road, 6th Floor, Neihu District, Taipei, TWN, 11494
Genetics Generation Advancement Corp is a Taiwan based company specialized in genetic testing and scientific information. It is engaged in providing services for the detection of genetic defects and prevention in newborns. Their main services include amniotic fluid chromosome chip screening, pre-implantation genetic diagnosis, and Molecular DNA testing diagnostics. The company is focused on the majority of areas of maternal precision medicine, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection, and precise health management. The business units of the company are the Genetic Testing Unit and Informatics business unit.

Genetics Generation Advancement Headlines

No Headlines